Clinical spectrum of extreme insulin resistance syndromes treated with rhIGF-1: A single-center experience - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Outcomes of rhIGF-1 Therapy in Patients with Severe Insulin Resistance Syndromes: Insights from a Single-Center Study

  • By

  • Nicola Improda

  • Harshini Katugampola

  • Manuela Cerbone

  • Pratik Shah

  • Saji Alexander

  • Abigail Atterbury

  • Smail Hadj-Rabia

  • Catherine J Peters

  • Robert K Semple

  • Mehul Tulsidas Dattani

  • January 28, 2026

Share

Original Source(s)

Clinical spectrum of extreme insulin resistance syndromes treated with rhIGF-1: A single-center experience

  • by Nicola Improda, Harshini Katugampola, Manuela Cerbone, Pratik Shah, Saji Alexander, Abigail Atterbury, Smail Hadj-Rabia, Catherine J Peters, Robert K Semple, Mehul Tulsidas Dattani

  • January 28, 2026

Related Content

Sex, Age, and Tumor Genetics to Inform Risk Stratification in Papillary Thyroid Cancer

Public health policy should be grounded in established evidence that acknowledges uncertainty: a response to The Lancet series on ultra-processed foods

Comparative effectiveness of statins, metformin, and vitamin D, for prevention of preeclampsia: a systematic review and network meta-analysis of randomized trials